Home
>
National Drug Code (NDC)
>
Nimbex
Nimbex - 0074-4378-05 - (Cisatracurium besylate)
Drug Information of Nimbex
| Product NDC: | 0074-4378 |
| Proprietary Name: | Nimbex |
| Non Proprietary Name: | Cisatracurium besylate |
| Active Ingredient(s): | 2 mg/mL & nbsp; Cisatracurium besylate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nimbex
| Product NDC: | 0074-4378 |
| Labeler Name: | Abbott Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020551 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101209 |
Package Information of Nimbex
| Package NDC: | 0074-4378-05 |
| Package Description: | 5 mL in 1 VIAL, SINGLE-DOSE (0074-4378-05) |
NDC Information of Nimbex
| NDC Code | 0074-4378-05 |
| Proprietary Name | Nimbex |
| Package Description | 5 mL in 1 VIAL, SINGLE-DOSE (0074-4378-05) |
| Product NDC | 0074-4378 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cisatracurium besylate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101209 |
| Marketing Category Name | NDA |
| Labeler Name | Abbott Laboratories |
| Substance Name | CISATRACURIUM BESYLATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
